of their diagnosis, and this rate is even lower for infected children. [4] [5] [6] Current guidelines by the Centers for Disease Control and Prevention (CDC) and United States Preventive Service Task Force recommend testing individuals with specific HCV risk factors. 7, 8 However, risk-based screening in the clinical setting is inadequate due to failure to identify high-risk behaviours among patients and low engagement by at-risk persons in routine medical care. [9] [10] [11] Pregnancy represents a unique time during which young, otherwise healthy adults may actively engage in medical care.
This includes vulnerable populations who have increasingly accessed prenatal care in recent decades due to expansion of coverage for prenatal care in US Medicaid plans. 12, 13 Thus, prenatal screening for HCV may be an effective outreach strategy to help close the diagnosis gap among adult women. Furthermore, recognition of HCV during pregnancy is critical to identify infants at risk of mother-to-child transmission (MTCT) of HCV. Birth to an infected mother carries an estimated 5.8% risk of MTCT and is the primary route of paediatric HCV infection. 14 To date, national guidelines advise risk-based HCV screening rather than universal HCV screening among pregnant women due to the lack of proven strategies to prevent MTCT. 7, 8, 15 This approach may miss a significant fraction of HCV-infected pregnant women. Moreover, the prevalence of HCV appears to be increasing among women of reproductive age in the US due to increased injection drug use. [15] [16] [17] [18] [19] Thus, an increasing number of infants may be at risk for vertically acquired HCV and potential adverse fetal outcomes including fetal growth restriction and low birth weight. Public health approaches to better understand the magnitude of HCV infection in women of reproductive age and subsequent risk to newborns are required.
By integrating data from 2 surveillance systems routinely maintained by the Ohio Department of Health (ODH), we sought to develop a new algorithm that could more fully ascertain the prevalence of HCV infection among pregnant women in Ohio.
| ME THODS

| Study population
We linked data from Vital Statistics (VS) records and the Ohio Disease Reporting System (ODRS), both maintained by ODH, to as- 
| Approach for identification of past/present HCV infection
We first identified all pregnant women reported as having past/present HCV infection in VS records (Method 1). We subsequently used data from ODRS to enhance identification of past/present HCV infection among pregnant women who may not have been reported as such in VS (Method 2; Figure 1 ). 
| Data and statistical analyses
We calculated, by calendar year, the proportion of total livebirths to all women identified as having past/present HCV infection 
| RE SULTS
| Interpretation
Consistent with other epidemiologic studies showing increasing rates of HCV infection in young adults, 18, 19 we observed an almost twofold rise in the prevalence of maternal HCV during the study period. While possibly due in part to higher screening rates over time, these data also mirror recent trends in opioid and heroin use among pregnant women and likely reflect a major increase in the proportion of pregnant women actually infected with HCV. 18, 19, 21, 22 The failure of VS records to capture large fractions of HCV- TA B L E 1 (Continued) pregnancy to mitigate MTCT risk, 14 anti-HCV treatment post-partum is advocated to eliminate MTCT risk in future pregnancies and reduce the mother's risk of progressive liver disease. 26 Awareness of active maternal HCV infection is also critical for ensuring appropriate evaluation and follow-up in the newborn infant following delivery. The failure of VS to capture 20% of women with confirmed present HCV infection during pregnancy is particularly concerning as HCV viraemia is the chief risk factor for MTCT. 
| Strengths of the study
This study has improved the accuracy of HCV surveillance among pregnant women using 2 data sources that should be readily available in most states (ie birth certificate records and mandatory disease reporting), suggesting that our approach may serve as a viable model for other states to follow. In addition, linking of births data with disease-specific surveillance data may provide an efficient mechanism for improving recognition of other maternal and perinatal conditions that are not subject to universal prenatal screening.
Furthermore, by highlighting discrepancies in disease status between birth certificate data and ODRS case records, public health professionals can identify individual cases where further action for disease notification and linkage to care are warranted. in less than 20-40% of acutely infected individuals and HCV treatment was unlikely to be offered to these women during the study period. 27 Furthermore, the methodology presented here is applicable to surveillance in Ohio in particular, but as mentioned above, it is anticipated that our approach may be transferrable to other states.
| Limitations of the data
| CON CLUS IONS
Using a new method to expand HCV case identification during pregnancy that capitalized on existing surveillance systems, we demonstrate that HCV infection in pregnant women continues to be under-recognized. With the availability of highly effective anti-HCV therapy, there may be novel opportunities for early treatment to prevent the development of liver disease in individual women and also reduce HCV transmission at a population level. Recognition of maternal HCV infection is also necessary to ensure that newborns at risk of MTCT receive appropriate testing and care. Further studies are needed to explore how our enhanced HCV case identification during pregnancy can be translated into improved rates of diagnosis and treatment among reproductive-aged women and newborns at risk of MTCT.
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